What causes elevation in PSA and liver enzymes?

Posted by admin on January 21st, 2010 No Comments

Dear viewer,

Prostate Specific Antigen (PSA) is blood test that is elevated in prostate cancer, benign prostate hypertrophy, prostate trauma, prostate infection, after prostate examination or ejaculation. Liver enzymes in blood can be elevated in many medical conditions. Some examples include viral hepatitis, medication effects, alcoholic liver damage, gallstone disease, cancer in the liver, excessive fat or iron in the liver etc. Therefore it is difficult to directly answer your question regarding relationship between elevated PSA and liver enzymes without more information.

Alkaline phosphatase is a liver enzyme that is also found in bone. Alkaline phosphatase can be elevated in liver disease and in bone diseases such as bone cancer and Paget’s disease of bone. In patients with prostate cancer that have spread to bone, both Prostate Specific Antigen (PSA) and Alkaline phosphatase can be elevated.

Thank you for your question!

Prostatism: Signs Having obtained the symptoms suggestive of outlet obstruction, the diagnosis should then be confirmed by the signs of outlet obstruction. On physical examination, the bladder may or may not be palpable. Rectal examination should normally reveal an enlarged prostate. However, it is the periurethral ...
Osseous Metastases Persistent bone pain in the back or hip region is one of the most common presenting symptoms of metastatic disease. The imaging modality of choice in this situation is the radionuclide bone scan. This will reveal the most common sites of spread to be ...
Atrasentan. Atrasentan (Abbott Laboratories' Xinlay, formerly ABT-627) is an oral, small-molecule, selective ET-A-receptor antagonist that appears to slow the progression of CaP. It is in Phase III trials, and Abbott submitted a new drug application (NDA) for the drug with the FDA at the ...
Leading Prostate Cancer Test ‘Clinically Useless’ PSA test doesn't detect tumor's severity, Stanford University study says The leading test to detect prostate cancer is "clinically useless" at determining the size or severity of a man's tumor, and is only of "limited" value at predicting cure rates from surgery to remove the ...
Prostate specific antigen in urinary tract infection Prostate specific antigen (PSA) has a reported sensitivity for prostatic adenocarcinoma of up to 80%. However, it lacks specificity. The reported positive predicted value of an elevated PSA (Hybritech Tandem-R PSA radioimmunoassay >4 ng/ml) for prostatic carcinoma in screening studies is only 28-33%. This ...

Posted in: Questions & Answers

Health and Prostate